Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 42.00 | 67.75 | 0.6199 | -0.9812 | |
| SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 109.00 | 67.75 | 1.6089 | 206.0682 | |
| SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 67.00 | 67.75 | 0.9889 | 0.7942 | |
| SK-BR-3 | Etoposide | 10 | uM | 4 | 156.25 | 63.10 | 48.00 | 67.75 | 0.7085 | -0.9307 |
| SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 74.00 | 67.75 | 1.0923 | 3.7311 | |
| SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 68.00 | 67.75 | 1.0037 | 1.0732 | |
| SK-BR-3 | Etoposide | 1 | uM | 4 | 156.25 | 63.10 | 52.00 | 67.75 | 0.7675 | -0.8487 |
| SK-BR-3 | NVP-TAE684 | 0.31623 | uM | 4 | 156.25 | 63.10 | 62.00 | 67.75 | 0.9151 | -0.1582 |
| SK-BR-3 | Nilotinib | 0.031623 | uM | 4 | 156.25 | 63.10 | 92.00 | 67.75 | 1.3579 | 38.5901 |
| SK-BR-3 | Nilotinib | 3.1623 | uM | 4 | 156.25 | 63.10 | 84.00 | 67.75 | 1.2399 | 15.2961 |
| SK-BR-3 | NVP-TAE684 | 0.01 | uM | 4 | 156.25 | 63.10 | 108.00 | 67.75 | 1.5941 | 188.2591 |
| SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 4 | 156.25 | 63.10 | 148.00 | 67.75 | 2.1845 | 4093.9433 |
| SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 109.00 | 67.75 | 1.6089 | 206.0682 | |
| SK-BR-3 | Etoposide | 0.1 | uM | 4 | 156.25 | 63.10 | 80.00 | 67.75 | 1.1808 | 9.1235 |
| SK-BR-3 | PLX-4720 | 0.0033113 | uM | 4 | 156.25 | 63.10 | 75.00 | 67.75 | 1.1070 | 4.3931 |
| SK-BR-3 | Nilotinib | 0.0033113 | uM | 4 | 156.25 | 63.10 | 68.00 | 67.75 | 1.0037 | 1.0732 |
| SK-BR-3 | PLX-4720 | 0.31623 | uM | 4 | 156.25 | 63.10 | 95.00 | 67.75 | 1.4022 | 53.1458 |
| SK-BR-3 | NVP-TAE684 | 0.031623 | uM | 4 | 156.25 | 63.10 | 91.00 | 67.75 | 1.3432 | 34.5856 |
| SK-BR-3 | Nilotinib | 0.31623 | uM | 4 | 156.25 | 63.10 | 44.00 | 67.75 | 0.6495 | -0.9704 |
| SK-BR-3 | NVP-TAE684 | 1 | uM | 4 | 156.25 | 63.10 | 127.00 | 67.75 | 1.8745 | 918.9974 |
| SK-BR-3 | Etoposide | 0.031623 | uM | 4 | 156.25 | 63.10 | 65.00 | 67.75 | 0.9594 | 0.3349 |
| SK-BR-3 | PLX-4720 | 1 | uM | 4 | 156.25 | 63.10 | 78.00 | 67.75 | 1.1513 | 6.9076 |
| SK-BR-3 | PLX-4720 | 0.031623 | uM | 4 | 156.25 | 63.10 | 47.00 | 67.75 | 0.6937 | -0.9436 |
| SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 62.00 | 67.75 | 0.9151 | -0.1582 | |
| SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 24.00 | 67.75 | 0.3542 | -0.9999 |